Drug and Therapeutics Bulletin is a peer-reviewed journal that provides independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB summarises the best available evidence to enable readers to make informed and unbiased choices regarding medicines and other treatments to help patients get the best care. DTB content includes opinion pieces, commentaries, summaries of recently published evidence as well as clinical reviews and articles on new medicines.
Drug and Therapeutics Bulletin adheres to the highest possible industry standards concerning publication ethics. Content is commissioned and undergoes a rigorous and transparent editorial process. DTB is also wholly independent of the pharmaceutical industry, Government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.
All content in DTB is commissioned and undergoes a rigorous and transparent editorial process: articles are peer-reviewed externally and internally, authors and DTB Editorial members are required to declare and publish any conflicts of interest.
DTB publishes reviews, editorials, select summaries and case reports. Read more about our content in the Welcome to the new Drug and Therapeutics Bulletin Editorial.